Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,542 | 23,048 | 23,067 | 43,585 | 79,219 |
| Marketable Securities | 91,203 | 133,394 | 153,361 | 140,225 | 112,935 |
| Receivables | 4,282 | 4,544 | 7,997 | 16,038 | 3,748 |
| TOTAL | $149,089 | $166,442 | $190,287 | $203,517 | $198,346 |
| Non-Current Assets | |||||
| PPE Net | 33,522 | 26,707 | 22,726 | 16,856 | 16,020 |
| Investments And Advances | 10,076 | 10,398 | 0 | 0 | 0 |
| Intangibles | 30,938 | 31,238 | 31,521 | 0 | 0 |
| Other Non-Current Assets | 2,898 | 5,205 | 5,147 | 1,625 | 527 |
| TOTAL | $77,434 | $73,548 | $59,393 | $18,482 | $16,547 |
| Total Assets | $226,523 | $239,990 | $249,680 | $221,999 | $214,893 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 364 | 974 | 1,030 |
| Accounts payable and accrued liabilities | 4,046 | 3,168 | 4,126 | 6,458 | 3,136 |
| Accrued Expenses | 4,035 | 5,016 | 3,606 | 1,974 | 1,763 |
| TOTAL | $18,174 | $18,779 | $18,915 | $21,448 | $10,773 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,579 |
| Deferred Revenues | 10,093 | 10,595 | 10,715 | 12,042 | 4,844 |
| Other Non-Current Liabilities | 329 | 339 | 0 | 0 | 0 |
| TOTAL | $1,579 | $2,839 | $3,809 | $5,000 | $1,579 |
| Total Liabilities | $19,753 | $21,618 | $22,724 | $26,448 | $12,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,467 | 7,459 | 7,419 | 7,409 | 6,981 |
| Common Shares | 52 | 52 | 52 | 49 | 49 |
| Retained earnings | -104,133 | -90,075 | -79,069 | -72,849 | -62,910 |
| Other shareholders' equity | -20,121 | -22,697 | -24,937 | -27,854 | -30,566 |
| TOTAL | $206,770 | $218,372 | $226,956 | $195,550 | $202,541 |
| Total Liabilities And Equity | $226,523 | $239,990 | $249,680 | $221,999 | $214,893 |